Emerald ash borer (EAB), Agrilus planipennis (Fairmaire; Coleoptera: Buprestidae), is decimating ash trees (Fraxinus spp.) in North America. Combatting EAB includes the use of insecticides; however, reported insecticide efficacy varies among published studies. This study assessed the effects of season of application, insecticide active ingredient, and insecticide application rate on green ash (Fraxinus pennsylvanica Marsh.) (Lamiales: Oleaceae) canopy decline caused by EAB over a 5-to 7-yr interval. Data suggested that spring treatments were generally more effective in reducing canopy decline than fall treatments, but this difference was not statistically significant. Lowest rates of decline (<5% over 5 yr) were observed in trees treated with imidacloprid injected annually in the soil during spring (at the higher of two tested application rates; 1.12 g/cm diameter at 1.3 m height) and emamectin benzoate injected biennially into the stem. All tested insecticides (dinotefuran, emamectin benzoate, and imidacloprid) under all tested conditions significantly reduced the rate of increase of dieback.
. In contrast, imidacloprid is effective on all sizes of ash trees (Smitley et al. 2007b) . Trees with up to 60% canopy dieback recovered following imidacloprid treatments (Smitley et al. 2007b) .
Trunk injections of emamectin benzoate produce 95% larval mortality (McCullough et al. 2011) . A 2-yr retreatment interval is recommended by all manufacturers and is effective at preventing tree mortality from EAB (McCullough et al. 2011) . Studies report that the active ingredient emamectin benzoate results in the most effective EAB control (Herms 2010 , Smitley et al. 2010 , McCullough et al. 2011 , McCullough and Mercader 2012 , Sadof et al. 2017 . Unlike soil-applied insecticides, tree injection requires drilling into the tree (Smitley et al. 2007b) .
High variation in insecticide efficacy has been reported among active ingredients, among individual trees, and across treatment sites (Smitley et al. 2007a) . Identical active ingredients showed efficacy in some trials but failed in others ). Multiple studies have demonstrated that the cost of tree removal commonly exceeds the cost of insecticide treatment (Herms 2010 , Smitley et al. 2010 , McCullough et al. 2011 , McCullough and Mercader 2012 . Therefore, there is a need for effective insecticide treatment options.
This study was intended to address gaps in the EAB literature regarding long-term survival of ash trees treated with insecticides. Specifically, our objectives were to determine: 1) the multi-year efficacy of dinotefuran, imidacloprid, dinotefuran + imidacloprid, and emamectin benzoate for EAB control, 2) the multi-year impact of seasonal treatment timing on the efficacy of soil-applied insecticides for EAB control, and 3) the effective dose of imidacloprid.
Materials and Methods
In January 2008, a single EAB-infested tree was found in Hazel Crest, IL by the Illinois Department of Agriculture EAB Trap Tree Program (Fig. 1) . A study site was established within an ongoing EAB infestation discovered in proximity to the trap tree, centered at approximately 41°33′25.2″N 87°42′10.8″W, and with a total of 205 green ash (F. pennsylvanica) trees growing across a 0.728 km 2 area. A wide boulevard and set of buildings in the center of the research plot created a 340-m-wide division of the area into two subplots. The 90 trees in the southern (S) subplot were dispersed over 750 m along Village Drive, while the 115 trees in the northern (N) subplot were dispersed over 610 m along Fountainbleau Drive. The trees in the two subplots differed significantly in their average DBH and Fig. 1 . Map of Hazel Crest, IL study site indicating location of green ash trees included in the study and the trap tree in which EAB was originally detected in the area.
the treatments applied in each (Table 1) and therefore, in addition to analyzing data as a whole, we also analyzed data by N and S subplots.
Branches were sampled in 2008 on trees with conspicuous canopy decline to confirm that the decline was a result of EAB activity. Eleven trees were sampled in the N subplot and ten in the S subplot. An aerial bucket truck was used to collect four branches, one from each cardinal direction. Branch samples were 5 to 10 cm in diameter and 91 cm (3 ft) long. Branches were peeled with draw knives and examined for EAB presence. In 2012, one randomly selected tree per treatment group per subplot was sampled.
Seven treatments were initially included in trials from May 2008 through August 2014: 1) untreated control (18 in N, nine in S); 2) spring imidacloprid (15 in N, seven in S); 3) fall imidacloprid (16 in N, seven in S); 4) spring dinotefuran (14 in N, seven in S); 5) fall dinotefuran (15 in N, seven in S); 6) spring imidacloprid plus dinotefuran (15 in N, seven in S); 7) fall imidacloprid plus dinotefuran (15 in N and seven in S) (Table 1) . Insecticide was applied at the label rate: for imidacloprid, 0.56 g/cm diameter at breast height (DBH); for dinotefuran, 1.34 g/cm DBH. Spring treatments were applied in May and fall treatments in November. Within each subplot, treatments were assigned to each tree using simple randomization with equal probabilities.
In March 2009 the Environmental Protection Agency changed its regulations allowing for the application of imidacloprid at 1.12 g/ cm DBH on ash trees. Additionally, tree injections of emamectin benzoate had recently been determined to be a promising technology for the control of EAB (McCullough 2008 (Table 1 ). Due to limited availability of trees at the time of treatment initiation, fall 2× imidacloprid and emamectin benzoate treatments were exclusively applied to the S subplot. Annual applications of treatments 1-9 were continued through the date of the final dieback assessment.
All treatments of imidacloprid (Xytect 75 WSP) and dinotefuran (Transtect 70 WSP) insecticide formulations (Rainbow Treecare Scientific Advancements, Minnetonka, MN) were applied by using an HTI 2000 soil injection probe (Rainbow Treecare Scientific Advancements), and 98.4 ml of aqueous insecticide solution per cm DBH of the tree was injected into the mineral soil matrix adjacent to the root flare, 15 cm below the soil surface, with one injection site per 2.54 cm DBH (i.e., 250 ml per injection). Emamectin benzoate in a 4% aqueous solution was applied by using the Tree IV micro-infusion system (TREE-äge, Arborjet, Woburn, MA) using one arborplug for every 5 cm DBH per manufacturer specifications.
Treatment efficacy was evaluated independently by two researchers using the Ash Canopy Thinning and Dieback Scale developed by Smitley et al. (2008) . The scale pictorially quantifies the percentage of canopy dieback in 10% increments. Canopies of trees in treatments 1-7 were rated for dieback in August of 2008 and bi-annually thereafter in June and August from 2009 through 2014. Baseline canopy dieback ratings for treatments 8-10 (fall and spring 2× imidacloprid and emamectin benzoate) were made in 2009. 
Statistical Methodology
Data were analyzed using R Statistical Software (R Core Development Team 2008). Tree size (DBH) at trial initiation was compared between the two subplots using a Welch's two sample t-test. Annual changes in canopy dieback were calculated both from the beginning of the study (2008) and from the time when all treatments were included (2010). Significant changes in canopy dieback were determined by contrasting dieback at each reassessment against the 2008 and --15 ± 14.5 5 ± 0.0 11 ± 9.9 16 ± 9.7 21 ± 18.8 P = 1.000 P = 1.000
P-values based on Mann-Whitney U-Tests (with Bonferroni correction) comparing canopy thinning from levels at first assessment (2008 or 2010). Mean canopy dieback, mean canopy dieback since 2008, and mean canopy dieback since 2010 were compared across treatments by using ANCOVA with type III sums of squares to address unequal sample sizes and potential interaction among independent variables. All ANCOVAs included treatment as the main effect controlled for DBH, year, and subplot. This analysis was performed using the 'Anova' function in the 'car' package, which allows for type determination of the sum of squares (Fox 2011) . To determine pairwise differences between treatments in canopy dieback and canopy change, post-hoc comparisons were performed by using Tukey's Honest Significant Difference (HSD) method. This analysis was performed with the 'HSD.test' function in the 'agricolae' package (De Mendiburu 2014) . This method was utilized to account for unequal sample sizes across groups and type 1 error rate. Statistical significance was defined at an alpha level of 0.05. Plots of trends were created using 'ggplot2' and 95% confidence bands were computed by a non-parametric loess method using 'geom_smooth' (Wickham 2009 ).
Results
In the N and S subplots in 2008 (the initiation of the study), 36 and 40%, respectively, of sampled trees with conspicuous dieback were positive for EAB. In 2012, 100% of branches sampled (from one randomly selected tree per treatment and subplot) were positive for EAB. Welch's two sample t-tests revealed a significant difference in DBH between subplots at the initiation of the study (P < 0.001). Mean DBH was 35.0 cm and 38.9 cm for N and S subplots, respectively (Fig. 2) 
Canopy Dieback Across Subplots
Canopy dieback increased significantly for untreated control trees between 2008 and 2014, from 10 to 93%, respectively (P < 0.001) ( Table 2 ). Spring applied and fall applied imidacloprid, dinotefuran, and imidacloprid plus dinotefuran treatments demonstrated a significant increase in percent canopy dieback over the 7-yr trial (P < 0.001) (Table 2; Figs. 3 and 4) . By 2014, all fall applied treatment trees had higher mean canopy dieback ratings than the spring applied equivalents, however these differences were not significant (P > 0.05). For treatments applied in 2010, there were no significant changes in dieback ratings for spring applied 2× imidacloprid (from 25 to 41%; P = 0.129) or emamectin benzoate (from 15 to 21%; P = 1.0) between 2010 and 2014 (Table 2; Figs. 3 and 5B). Fall applied treatments of 2× imidacloprid had a significant difference in canopy ratings, from 8 to 47% dieback (P < 0.001). 
Canopy Dieback Accounting for Subplot
There was a significant effect (P < 0.001) of year, subplot, and treatment in predicting canopy dieback in 2014, change in canopy dieback from 2008 to 2014, and change in canopy dieback from 2010 to 2014, whereas DBH did not have a significant effect on any of these measures (P > 0.1; Table 5 ). Post-hoc analysis revealed significant pair-wise differences in mean canopy dieback between the untreated trees and all other treatments (Fig. 6A) . Additionally, mean canopy dieback was significantly less for emamectin benzoate, compared to all other treatments, except fall 2× imidacloprid and spring 2× imidacloprid (Fig. 6A) . From 2008 to 2014, mean increase in canopy dieback for the untreated trees was significantly higher than for all other treatments tested over this entire interval (Fig. 6B) . From 2010 to 2014, mean increase in canopy dieback was significantly higher for the untreated trees than for all other treatments. Additionally, emamectin benzoate and spring 2× imidacloprid trees experienced significantly less change in canopy dieback compared to spring and fall imidacloprid, fall dinotefuran, and fall imidacloprid plus dinotefuran (Fig. 6C) . By 2014, all trees in the southern subplot, except spring 2× imidacloprid and emamectin benzoate treated trees, had significant increases in canopy dieback (P = 0.316 and 1.0, respectively) ( Table 4 ). In the northern subplot, all trees except spring 2× imidacloprid had significant increases in canopy dieback by 2014 (P = 0.443). The absence of a detectable increase in dieback for spring 2× imidacloprid and emamectin benzoate treatments (begun in 2010), which was not detected in any of the treatments begun in 2008, could be attributed to the relatively shorter treatment and monitoring period for the former.
Discussion
Branch sampling indicated that canopy dieback could be attributed to the EAB infestation. Trees in the N subplot tended to be smaller than those in the S subplot (Fig. 2) , however, the difference Ctl (n = 9) 2 ± 4.4 9 ± 4.5 12 ± 11.5 13 ± 9.0 18 ± 15.8 83 ± 13.2 92 ± 7.1 P = 0. 11 ± 7.9 21 ± 6.0 15 ± 9.6 17 ± 5.2 24 ± 28.5 26 ± 9.9 46 ± 21.5 P = 1.000 P = 1.000 P = 0.007 Fa. Din. (n = 7) 7 ± 11.1 18 ± 3.5 16 ± 22.7 20 ± 19.1 28 ± 31.3 55 ± 29.9 67 ± 21.8 P = 1.000 P = 0.616 P = 0.011 Sp. Im. Din. (n = 7) 4 ± 5.3 6 ± 8.0 7 ± 4.9 13 ± 2.7 12 ± 12.9 35 ± 18.3 36 ± 15.1 P = 1.000 P = 1.000 P = 0.005 Fa. Im. Din. (n = 7) 5 ± 5.5 16 ± 2.5 13 ± 9.9 21 ± 6.1 23 ± 26. --15 ± 14.5 5 ± 0.0 11 ± 9.9 16 ± 9.7 21 ± 18.8 P = 1.000 P = 1.000 in mean tree diameter between subplots was small (about 10%), and an ANCOVA did not reveal DBH having a significant influence on dieback. Significant dieback for the untreated control trees occurred sooner in the N subplot than the S subplot (Tables 3 and 4) . However, by the end of the experiment, the two subplots' control canopy dieback ratings reached similar levels of decline: 94 and 92% for N and S, respectively. Like prior studies , Herms 2010 , Smitley et al. 2010 , McCullough et al. 2011 , McCullough and Mercader 2012 , Herms and McCullough 2014 , all insecticide treatments resulted in some degree of control, as evidenced by significantly less change in canopy dieback from 2008 (or 2010) compared to untreated control trees ( Fig. 3; Fig. 6B and C). Nonetheless, fall and spring treatments of imidacloprid (at the 1× dose level), dinotefuran, and imidacloprid plus dinotefuran did not prevent significant tree decline over the 6 yr of treatment (Tables 2-4), in congruence with findings from Gandhi et al. (2007) .
Values for mean reductions in canopy thinning suggested that fall-applied treatments were less effective than spring-applied treatments; however, these differences were not statistically significant for any particular insecticide treatment (Figs. 4 and 6 ). It is possible that this trend was an artifact of lag time between initial application of spring and fall treatments, and further studies are necessary to establish unequivocally whether application timing has a meaningful effect on long-term treatment efficacy.
Imidacloprid and dinotefuran in combination were not superior to either insecticide singly in reducing dieback (Fig. 6) , and thus there was no additive effect from applying these insecticides simultaneously. According to Herms et al. (2009) , dinotefuran's recommended application time is mid-to late-spring while imidacloprid's recommended application time is early-to mid-spring ). Since the imidacloprid plus dinotefuran treatments were not applied in mid-spring, at least one active ingredient may have been applied at a nonoptimal time.
Data from 2010 and 2014 (over which time all nine insecticide treatments could be compared) indicated that emamectin benzoate-treated trees on average suffered the least increase in dieback (Fig. 6C) . However, emamectin benzoate was not statistically more effective at slowing thinning than several other insecticide treatments, including 2× imidacloprid (in fall or spring) or spring dinotefuran applied with or without imidacloprid (Fig. 6C) .
While ash trees are able to recover from 60% canopy dieback (Smitley et al. 2007b) , practitioners generally consider only 30% canopy dieback to be an acceptable level of damage. In our study, only emamectin benzoate maintained trees below this threshold (Table 4) , and thus according to our results only emamectin benzoate could potentially be considered efficacious in controlling EAB. However, trends illustrated in Figs. 3-5 imply that increasing canopy dieback was not stopped or reversed by any treatment, hence it is possible that, had the study been continued, emamectin benzoate would not have prevented mean damage levels from crossing the 30% threshold. Nonetheless, our finding that trees treated either with emamectin benzoate or imidacloprid (applied at the revised [i.e., 1.12 g/cm DBH] label rate in spring) did not have significant increases in canopy dieback by the end of the study is encouraging. 
